Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.

Sanguinetti M, Cantón E, Torelli R, Tumietto F, Espinel-Ingroff A, Posteraro B.

Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02693-18. doi: 10.1128/AAC.02693-18. [Epub ahead of print]

PMID:
31061161
2.

Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity.

Gil-Alonso S, Quindós G, Cantón E, Eraso E, Jauregizar N.

Rev Iberoam Micol. 2019 Jan - Mar;36(1):24-29. doi: 10.1016/j.riam.2018.12.001. Epub 2019 Mar 2.

PMID:
30837186
3.

Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data.

Ruiz-Gaitán AC, Cantón E, Fernández-Rivero ME, Ramírez P, Pemán J.

Int J Antimicrob Agents. 2019 May;53(5):541-546. doi: 10.1016/j.ijantimicag.2019.02.005. Epub 2019 Feb 12.

PMID:
30769198
4.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

5.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

6.

Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.

Fernández-Rivero ME, Del Pozo JL, Valentín A, de Diego AM, Pemán J, Cantón E.

J Fungi (Basel). 2017 Mar 22;3(1). pii: E16. doi: 10.3390/jof3010016.

7.

Time-kill assays of amphotericin B plus anidulafungin against Candida tropicalis biofilms formed on two different biomaterials.

Fernández-Rivero ME, Del Pozo JL, Ramírez P, Valentín E, Ruiz-Gaitán A, Pemán J, Cantón E.

Int J Artif Organs. 2017 Oct 18:0. doi: 10.5301/ijao.5000652. [Epub ahead of print]

PMID:
29048702
8.

[Activity of amphotericin B and anidulafungin, alone and combined, against Candida tropicalis biofilms developed on Teflon® and titanium].

Fernández-Rivero ME, Del Pozo JL, Valentín A, Fornes V, Molina de Diego A, Pemán J, Cantón E.

Rev Iberoam Micol. 2017 Jul - Sep;34(3):175-179. doi: 10.1016/j.riam.2017.01.002. Epub 2017 Jun 16. Spanish.

PMID:
28601403
9.

Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.

Ruiz Gaitán AC, Moret A, López Hontangas JL, Molina JM, Aleixandre López AI, Cabezas AH, Mollar Maseres J, Arcas RC, Gómez Ruiz MD, Chiveli MÁ, Cantón E, Pemán J.

Rev Iberoam Micol. 2017 Jan - Mar;34(1):23-27. doi: 10.1016/j.riam.2016.11.002. Epub 2017 Jan 25.

PMID:
28131716
10.

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.

Espinel-Ingroff A, Arendrup M, Cantón E, Cordoba S, Dannaoui E, García-Rodríguez J, Gonzalez GM, Govender NP, Martin-Mazuelos E, Lackner M, Lass-Flörl C, Linares Sicilia MJ, Rodriguez-Iglesias MA, Pelaez T, Shields RK, Garcia-Effron G, Guinea J, Sanguinetti M, Turnidge J.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01792-16. doi: 10.1128/AAC.01792-16. Print 2017 Jan.

11.

In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.

Valentín A, Cantón E, Pemán J, Fernandez-Rivero ME, Tormo-Mas MA, Martínez JP.

J Antimicrob Chemother. 2016 Dec;71(12):3449-3452. Epub 2016 Aug 19.

PMID:
27543657
12.

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice.

Solano AR, Cardoso FC, Romano V, Perazzo F, Bas C, Recondo G, Santillan FB, Gonzalez E, Abalo E, Viniegra M, Michel JD, Nuñez LM, Noblia CM, Mc Lean I, Canton ED, Chacon RD, Cortese G, Varela EB, Greco M, Barrientos ML, Avila SA, Vuotto HD, Lorusso A, Podesta EJ, Mando OG.

Oncotarget. 2016 Jul 24;8(36):60487-60495. doi: 10.18632/oncotarget.10814. eCollection 2017 Sep 1.

13.

[Candida biofilm-related infections].

Del Pozo JL, Cantón E.

Rev Iberoam Micol. 2016 Jul-Sep;33(3):176-83. doi: 10.1016/j.riam.2015.06.004. Epub 2015 Aug 17. Review. Spanish.

PMID:
27395021
14.

Candidemia in major burns patients.

Renau Escrig AI, Salavert M, Vivó C, Cantón E, Pérez Del Caz MD, Pemán J.

Mycoses. 2016 Jun;59(6):391-8. doi: 10.1111/myc.12488. Epub 2016 Mar 2.

PMID:
26931414
15.

Improvement and efficient display of Bacillus thuringiensis toxins on M13 phages and ribosomes.

Pacheco S, Cantón E, Zuñiga-Navarrete F, Pecorari F, Bravo A, Soberón M.

AMB Express. 2015 Dec;5(1):73. doi: 10.1186/s13568-015-0160-1. Epub 2015 Nov 25.

16.

Erratum to: Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey.

Faria-Ramos I, Neves-Maia J, Ricardo E, Santos-Antunes J, Silva AT, Costa-de-Oliveira S, Cantón E, Rodrigues AG, Pina-Vaz C.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2137. doi: 10.1007/s10096-015-2471-1. No abstract available.

PMID:
26292937
17.

Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.

Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E, Carver PL, Chen SC, Eschenauer G, Getsinger DL, Gonzalez GM, Govender NP, Grancini A, Hanson KE, Kidd SE, Klinker K, Kubin CJ, Kus JV, Lockhart SR, Meletiadis J, Morris AJ, Pelaez T, Quindós G, Rodriguez-Iglesias M, Sánchez-Reus F, Shoham S, Wengenack NL, Borrell Solé N, Echeverria J, Esperalba J, Gómez-G de la Pedrosa E, García García I, Linares MJ, Marco F, Merino P, Pemán J, Pérez Del Molino L, Roselló Mayans E, Rubio Calvo C, Ruiz Pérez de Pipaon M, Yagüe G, Garcia-Effron G, Guinea J, Perlin DS, Sanguinetti M, Shields R, Turnidge J.

Antimicrob Agents Chemother. 2015 Nov;59(11):6725-32. doi: 10.1128/AAC.01250-15. Epub 2015 Aug 17.

18.

In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.

Gil-Alonso S, Jauregizar N, Cantón E, Eraso E, Quindós G.

Antimicrob Agents Chemother. 2015;59(6):3615-8. doi: 10.1128/AAC.04474-14. Epub 2015 Mar 23.

19.

Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility.

Martí-Carrizosa M, Sánchez-Reus F, March F, Cantón E, Coll P.

Antimicrob Agents Chemother. 2015;59(6):3570-3. doi: 10.1128/AAC.04922-14. Epub 2015 Mar 16.

20.

Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves.

Gil-Alonso S, Jauregizar N, Cantón E, Eraso E, Quindós G.

Diagn Microbiol Infect Dis. 2015 May;82(1):57-61. doi: 10.1016/j.diagmicrobio.2015.01.010. Epub 2015 Feb 2.

PMID:
25703894
21.

Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey.

Faria-Ramos I, Neves-Maia J, Ricardo E, Santos-Antunes J, Silva AT, Costa-de-Oliveira S, Cantón E, Rodrigues AG, Pina-Vaz C.

Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2241-7. doi: 10.1007/s10096-014-2194-8. Epub 2014 Jul 11. Erratum in: Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2137.

PMID:
25012821
22.

Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.

Espinel-Ingroff A, Pfaller MA, Bustamante B, Canton E, Fothergill A, Fuller J, Gonzalez GM, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Szeszs MW, St-Germain G, Bonfietti LX, Guarro J, Turnidge J.

Antimicrob Agents Chemother. 2014;58(4):2006-12. doi: 10.1128/AAC.02615-13. Epub 2014 Jan 13.

23.

Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.

Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Ostrosky-Zeichner L, Pelaez T, St-Germain G, Turnidge J.

Antimicrob Agents Chemother. 2014;58(2):916-22. doi: 10.1128/AAC.02020-13. Epub 2013 Nov 25.

24.

Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J.

Antimicrob Agents Chemother. 2013 Dec;57(12):5836-42. doi: 10.1128/AAC.01519-13. Epub 2013 Sep 9.

25.

Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.

Hazirolan G, Canton E, Sahin S, Arikan-Akdagli S.

Antimicrob Agents Chemother. 2013 Oct;57(10):4841-7. doi: 10.1128/AAC.00850-13. Epub 2013 Jul 22.

26.

Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method.

Cantón E, Pemán J, Iñiguez C, Hervás D, Lopez-Hontangas JL, Pina-Vaz C, Camarena JJ, Campos-Herrero I, García-García I, García-Tapia AM, Guna R, Merino P, Pérez del Molino L, Rubio C, Suárez A; FUNGEMYCA Study Group.

J Clin Microbiol. 2013 Aug;51(8):2691-5. doi: 10.1128/JCM.01230-13. Epub 2013 Jun 12.

27.

[Microbiological procedures for the diagnosis, management, and study of invasive fungal infections].

Canton E, García-Rodríguez J, Martín-Mazuelos E, Pemán J, Guinea J.

Enferm Infecc Microbiol Clin. 2014 Jun-Jul;32(6):375-9. doi: 10.1016/j.eimc.2013.01.008. Epub 2013 Mar 15. Spanish.

PMID:
23499525
28.

[Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].

García-Rodríguez J, Cantón E, Pemán J, Alvarez M, Ezpeleta G, Gómez-Nieto A, Iglesias I, Martín-Mazuelos E, Ramírez-de Ocariz I, Rezusta A, Royo-García G; Grupo de Estudio FUNGEMYCA.

Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):363-8. doi: 10.1016/j.eimc.2012.09.018. Epub 2013 Feb 8. Spanish.

PMID:
23398860
29.

Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.

Cantón E, Pemán J, Hervás D, Espinel-Ingroff A.

J Antimicrob Chemother. 2013 Apr;68(4):864-8. doi: 10.1093/jac/dks489. Epub 2012 Dec 9.

PMID:
23228935
30.

Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.

Cantón E, Pemán J, Hervás D, Iñiguez C, Navarro D, Echeverría J, Martínez-Alarcón J, Fontanals D, Gomila-Sard B, Buendía B, Torroba L, Ayats J, Bratos A, Sánchez-Reus F, Fernández-Natal I; FUNGEMYCA Study Group.

J Clin Microbiol. 2012 Dec;50(12):3921-6. doi: 10.1128/JCM.01730-12. Epub 2012 Sep 26.

31.

Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

Espinel-Ingroff A, Aller AI, Canton E, Castañón-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill A, Fuller J, Govender N, Hagen F, Illnait-Zaragozi MT, Johnson E, Kidd S, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, St-Germain G, Trilles L, Turnidge J.

Antimicrob Agents Chemother. 2012 Nov;56(11):5898-906. doi: 10.1128/AAC.01115-12. Epub 2012 Sep 4.

32.

Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.

Garcia-Effron G, Canton E, Pemán J, Dilger A, Romá E, Perlin DS.

J Antimicrob Chemother. 2012 Nov;67(11):2739-48. doi: 10.1093/jac/dks271. Epub 2012 Aug 6.

33.

Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance.

Gant CM, Rosingh AW, López-Hontangas JL, van der Heijden M, González-Morán F, Bijlsma JJ, Canton E; RedMiva (Network of Microbiological Vigilance of Comunidad Valenciana).

Antimicrob Agents Chemother. 2012 Sep;56(9):4988-9. doi: 10.1128/AAC.01201-12. Epub 2012 Jul 2. No abstract available.

34.

Voriconazole inhibits biofilm formation in different species of the genus Candida.

Valentín A, Cantón E, Pemán J, Martínez JP.

J Antimicrob Chemother. 2012 Oct;67(10):2418-23. doi: 10.1093/jac/dks242. Epub 2012 Jun 25.

PMID:
22733651
35.

Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles.

Teixeira-Santos R, Rocha R, Moreira-Rosário A, Monteiro-Soares M, Cantón E, Rodrigues AG, Pina-Vaz C.

J Clin Microbiol. 2012 Aug;50(8):2748-54. doi: 10.1128/JCM.00610-12. Epub 2012 Jun 12.

36.

Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.

Martos AI, Martín-Mazuelos E, Romero A, Serrano C, González T, Almeida C, Puche B, Cantón E, Pemán J, Espinel-Ingroff A.

Diagn Microbiol Infect Dis. 2012 May;73(1):53-6. doi: 10.1016/j.diagmicrobio.2012.01.006. Epub 2012 Apr 4.

PMID:
22480568
37.

Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.

Pfaller MA, Espinel-Ingroff A, Canton E, Castanheira M, Cuenca-Estrella M, Diekema DJ, Fothergill A, Fuller J, Ghannoum M, Jones RN, Lockhart SR, Martin-Mazuelos E, Melhem MS, Ostrosky-Zeichner L, Pappas P, Pelaez T, Peman J, Rex J, Szeszs MW.

J Clin Microbiol. 2012 Jun;50(6):2040-6. doi: 10.1128/JCM.00248-12. Epub 2012 Mar 29.

38.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group.

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
39.

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Pemán J, Cantón E, Linares-Sicilia MJ, Roselló EM, Borrell N, Ruiz-Pérez-de-Pipaon MT, Guinea J, García J, Porras A, García-Tapia AM, Pérez-Del-Molino L, Suárez A, Alcoba J, García-García I.

J Clin Microbiol. 2011 Dec;49(12):4158-63. doi: 10.1128/JCM.05474-11. Epub 2011 Oct 19.

40.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D; FUNGEMYCA Study Group.

Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6. doi: 10.1128/AAC.00466-11. Epub 2011 Sep 19.

41.

Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species.

Garcia-Effron G, Canton E, Pemán J, Dilger A, Romá E, Perlin DS.

J Clin Microbiol. 2011 Sep;49(9):3257-61. doi: 10.1128/JCM.00508-11. Epub 2011 Jul 27.

42.

Differentiation of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis by specific PCR amplification of the RPS0 intron.

del Pilar Vercher M, García Martínez JM, Cantón E, Pemán J, Gómez García MM, Gómez EV, del Castillo Agudo L.

Int J Med Microbiol. 2011 Aug;301(6):531-5. doi: 10.1016/j.ijmm.2011.02.001. Epub 2011 May 13.

PMID:
21570908
43.

Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi.

Espinel-Ingroff A, Canton E, Fothergill A, Ghannoum M, Johnson E, Jones RN, Ostrosky-Zeichner L, Schell W, Gibbs DL, Wang A, Turnidge J.

J Clin Microbiol. 2011 Jul;49(7):2568-71. doi: 10.1128/JCM.00393-11. Epub 2011 May 4.

44.

Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates.

Espinel-Ingroff A, Cantón E, Pelaez T, Pemán J.

Diagn Microbiol Infect Dis. 2011 May;70(1):54-9. doi: 10.1016/j.diagmicrobio.2010.12.010.

PMID:
21513843
45.

In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?

Espinel-Ingroff A, Cantón E.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:3-9. doi: 10.1016/S0213-005X(11)70002-7. Review.

PMID:
21420570
46.

[Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].

Pemán J, Cantón E, Miñana JJ, Florez JA, Echeverria J, Ortega DN, Alarcón JM, Fontanals D, Sard BG, Moreno BB, Torroba L, Ayats J, Pérez MÁ, Fernández MA, Reus FS, Natal IF, García GR, Ezpeleta G, Martín-Mazuelos E, Iglesias I, Rezusta A, de Ocariz IR, Nieto AG; el Grupo de Estudio FUNGEMYCA.

Rev Iberoam Micol. 2011 Apr-Jun;28(2):91-9. doi: 10.1016/j.riam.2011.02.005. Epub 2011 Mar 3. Spanish.

PMID:
21376831
47.

Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, Rinaldi MG, Canton E, Turnidge J.

J Clin Microbiol. 2010 Sep;48(9):3251-7. doi: 10.1128/JCM.00536-10. Epub 2010 Jun 30.

48.

In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.

Cantón E, Espinel-Ingroff A, Pemán J, del Castillo L.

Antimicrob Agents Chemother. 2010 May;54(5):2194-7. doi: 10.1128/AAC.01538-09. Epub 2010 Feb 9.

49.

Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.

Martos AI, Romero A, González MT, González A, Serrano C, Castro C, Pemán J, Cantón E, Martín-Mazuelos E.

Med Mycol. 2010 Sep;48(6):858-61. doi: 10.3109/13693781003586943.

PMID:
20144131
50.

Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.

Espinel-Ingroff A, Canton E, Peman J, Martín-Mazuelo E.

Antimicrob Agents Chemother. 2010 Mar;54(3):1347-50. doi: 10.1128/AAC.01324-09. Epub 2009 Dec 22.

Supplemental Content

Loading ...
Support Center